David Lanfear, M.D., M.S.

Board Member and Research Committee Vice Chair

Henry Ford Vice President of Research and Chief Scientific Officer; Co-Director, Center for Individualized and Genomic Medicine Research

David Lanfear, M.D., M.S., FHFSA is System Vice President of Research and Chief Scientific Officer for Henry Ford Health. He is also Co-Director of the Center for Individualized and Genomic Medicine Research (CIGMA), a practicing transplant cardiologist, and a clinician-scientist focused on precision medicine and genomics, as well as an active clinical trialist with experience in single and multicenter trials.

He has been continuously funded by the NIH for his entire career and has produced more than 170 published manuscripts, reaching high-impact journals including JAMA, NEJM, and Nature: Medicine. He is nationally recognized in academic medicine previously serving on the HFSA Board of Directors, the AHA Genomics and Precision Medicine Leadership council, and ACC Heart Failure and Transplant Committee, and currently is on the AHA Genomics and Precision Medicine leadership committee. He is a standing member of NIH grant review panel (CCHS), an Associate Editor at Circulation: Heart Failure, has previously served as associate editor for JCF, and currently serves on the editorial boards of JACC: Heart Failure, Heart Failure Reviews, JACC:Cardio-Oncology, and JACC: Basic to Translational Science.

Lanfear received his medical degree from the University of Michigan Medical School and completed his residency and fellowship at Barnes-Jewish Hospital at Washington University Medical Center in Missouri.